Concurrent Speaker :
Arielle Elkrief, MD
McGill University / Centre de recherche de l'Université de Montreal (CRCHUM)
Arielle Elkrief, MD received her MD from the University of Sherbrooke in 2015 and is currently completing her residency training in Medical Oncology at McGill University. She joined Dr. Bertrand Routy's laboratory at the University of Montreal Reseach Center (CRCHUM) to work on the gut microbiome. Dr. Elkrief's research focuses on the deleterious impact of antibiotics on patients receiving cancer therapies including immune checkpoint inhibitors (ICI). Her objective is to demonstrate that the gut microbiota composition has a major impact on ICI efficacy in various cancers.
Thursday, September 13
1:45 PM – 3:15 PM